Foghorn Therapeutics Inc. Common Stock
$4.15
-$0.02 (-0.48%)
$4.14Day Range$4.32
Key Statistics
Market Cap
$247.64M
Shares Outstanding
59.4M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Oct 23, 2020
Round Lot
100
Locale
US
Trading Data
Day Open
$4.27
Day High
$4.32
Day Low
$4.14
Volume
149.2K
VWAP
$4.23
Prev Close
$4.17
Transactions
--
Acc. Volume
--
About Foghorn Therapeutics Inc. Common Stock
Foghorn Therapeutics Inc is a clinical stage, precision therapeutics biotechnology company focused on pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression through selectively targeting the chromatin regulatory system. Its proprietary platform is designed to provide an integrated, mechanistic understanding of interactions within the chromatin regulatory system, supporting the identification and validation of potential therapeutic targets. The company's flagship program is FHD-909.
PHARMACEUTICAL PREPARATIONSSIC 2834106 employees500 TECHNOLOGY SQUARE, CAMBRIDGE, MA, 02139617-586-3100IPO Oct 23, 2020US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001822462
- Composite FIGI
- BBG00HFZPB88
- Share Class FIGI
- BBG00HFZPB97
- Ticker Root
- FHTX
- SIC Code
- 2834
About Foghorn Therapeutics Inc. Common Stock (FHTX) Stock
Foghorn Therapeutics Inc. Common Stock (FHTX) closed the 2026-09-17 session at $4.15, down 0.48% versus the previous close (-0.02). The stock opened at $4.27 and traded between $4.14 and $4.32 during that session. Session trading volume was 149K shares. The volume-weighted average price (VWAP) is $4.23.
Foghorn Therapeutics Inc is a clinical stage, precision therapeutics biotechnology company focused on pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression through selectively targeting the chromatin regulatory system. Its proprietary platform is designed to provide an integrated, mechanistic understanding of interactions within the chromatin regulatory system, supporting the identification and validation of potential therapeutic targets. The company's flagship program is FHD-909.
Foghorn Therapeutics Inc. Common Stock has a market capitalization of $247.6 million. The company operates in the PHARMACEUTICAL PREPARATIONS industry classification. FHTX is listed on the XNAS exchange. The company employs approximately 106 people. Foghorn Therapeutics Inc. Common Stock is headquartered in CAMBRIDGE, MA. The recorded listing date is 2020-10-23.
On this page you can find market FHTX stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the PHARMACEUTICAL PREPARATIONS sector.